We used the TipRanks Stock Screener Tool, to determine three mid-cap companies with low Price-to-Earnings (P/E) ratios, a ...

Silver futures have surged in a powerful accelerating uptrend, driving from the 48.05 cycle pivot low into a session high of 55.93. This advance completes a textbook mean-reversion trajectory from the ...

The current overbought reading near 55.93 fits well within this projection, showing price accelerating ahead of the projected ...

On Tuesday, Alphabet's stock closed 61.2% above its 200-DMA, which is the most since it closed 61.7% above it on June 7, 2005. In comparison, the average distance the stock has been above the 200-DMA ...

Dayforce, Inc. remains resilient with decent revenue growth, stable client retention, and continued demand for its HCM ...

MicroStrategy Inc (NASDAQ: MSTR) didn't just follow Bitcoin (CRYPTO: BTC) lower this month — it got dragged behind the pickup ...

Amazon.com Inc. (NASDAQ: AMZN) was staging a strong comeback in 2025. However, AMZN stock has fallen about 12% since Nov. 1, ...

Ethereum faces a challenging environment as it navigates a mix of technical developments and broad market weakness.

In biotech, success often begins in the lab — and for CRISPR pioneers, every clinical trial feels like a moonshot. Gene-editing is not just science but rewriting life itself. For clinical-stage ...

As of yesterday’s market close, Netflix is the only Big Tech company whose stock is trading at four figures, but that will soon change. The TV streaming giant, whose shares closed at $1,089 on ...

Meme stocks and the internet culture around them can seem silly, but their wins and losses are no joke. These are the best-performing meme stocks this month. Many, or all, of the products featured on ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...